Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Feb:162:142-150.
doi: 10.1016/j.antiviral.2018.12.015. Epub 2018 Dec 28.

Third Tofo Advanced Study Week on Emerging and Re-emerging Viruses, 2018

Athanase Badolo  1 , Felicity Burt  2 , Susan Daniel  3 , Rachel Fearns  4 , Eduardo Samo Gudo  5 , Margaret Kielian  6 , Julien Lescar  7 , Yi Shi  8 , Albrecht von Brunn  9 , Susan R Weiss  10 , Rolf Hilgenfeld  11
Affiliations
Review

Third Tofo Advanced Study Week on Emerging and Re-emerging Viruses, 2018

Athanase Badolo et al. Antiviral Res. 2019 Feb.

Abstract

The Third Tofo Advanced Study Week on Emerging and Re-Emerging Viruses (3rd TASW) was held in Praia do Tofo, Mozambique, from September 02 to 06, 2018. It brought together 55 participants from 10 African countries as well as from Belgium, China, Germany, Singapore, and the USA. Meeting sessions covered aspects of the epidemiology, diagnosis, molecular and structural biology, vaccine development, and antiviral drug discovery for emerging RNA viruses that are current threats in Africa and included flaviviruses (dengue and Zika), alphaviruses (chikungunya), coronaviruses, filoviruses (Ebola), influenza viruses, Crimean Congo hemorrhagic fever virus, Rift Valley fever Virus, Lassa virus, and others. Data were presented on recent flavivirus and/or chikungunyavirus outbreaks in Angola, Burkina Faso, and Mozambique. In addition, these viruses are endemic in many sub-Saharan countries. The TASW series on emerging viruses is unique in Africa and successful in promoting collaborations between researchers in Africa and other parts of the world, as well as among African scientists. This report summarizes the lectures held at the meeting and highlights advances in the field.

PubMed Disclaimer

References

    1. Abdelnabi R., Jochmans D., Verbeken E., Neyts J., Delang L. Antiviral treatment efficiently inhibits chikungunya virus infection in the joints of mice during the acute but not during the chronic phase of the infection. Antivir. Res. 2018;149:113–117. doi: 10.1016/j.antiviral.2017.09.016. - DOI - PubMed
    1. Agostini M.L., Andres E.L., Sims A.C., Graham R.L., Sheahan T.P., Lu X., Smith E.C., Case J.B., Feng J.Y., Jordan R., Ray A.S., Cihlar T., Siegel D., Mackman R.L., Clarke M.O., Baric R.S., Denison M.R. Coronavirus susceptibility to the antiviral Remdesivir (GS-5734) Is mediated by the viral polymerase and the proofreading exoribonuclease. MBio. 2018;9 doi: 10.1128/mBio.00221-18. pii: e00221-18. - DOI - PMC - PubMed
    1. António V.S., Muianga A.F., Wieseler J., Pereira S.A., Monteiro V.O., Mula F., Chelene I., Chongo I.S., Oludele J.O., Kümmerer B.M., Gudo E.S. Seroepidemiology of chikungunya virus among febrile patients in eight health facilities in central and northern Mozambique, 2015-2016. Vector Borne Zoonotic Dis. 2018;18:311–316. doi: 10.1089/vbz.2017.2227. - DOI - PubMed
    1. Banerjee S., Chakrabarti A., Jha B.K., Weiss S.R., Silverman R.H. Cell-type-specific effects of RNase L on viral induction of beta interferon. MBio. 2014;5 doi: 10.1128/mBio.00856-14. e00856-14. - DOI - PMC - PubMed
    1. Barba-Spaeth G., Dejnirattisai W., Rouvinski A., Vaney M.C., Medits I., Sharma A., Simon-Lorière E., Sakuntabhai A., Cao-Lormeau V.M., Haouz A., England P., Stiasny K., Mongkolsapaya J., Heinz F.X., Screaton G.R., Rey F.A. Structural basis of potent Zika-dengue virus antibody cross-neutralization. Nature. 2016;536:48–53. doi: 10.1038/nature18938. - DOI - PubMed

Publication types